{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:19:08Z","timestamp":1794359948974,"version":"4.9.0"},"reference-count":29,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Autoimmune thyroiditis (AIT) is often reported patients with PCOS, and may co-occur with altered metabolic risk markers. The aims of this study were to assess baseline differences according to thyroid autoimmunity status, evaluate adjusted associations between thyroid autoimmunity and metabolic parameters, examine associations with PCOS phenotype distribution, and perform k-means clustering to explore data-driven subgroups and their autoimmune enrichment. Materials and Methods: We performed a retrospective cohort study of 651 women with PCOS, comparing those without AIT (n = 506) versus with AIT (n = 145). Associations between AIT and continuous outcomes (HDL; composite metabolic score) were evaluated using robust linear regression with HC3 standard errors and age modeled with a natural cubic spline (3 knots). The association between AIT and phenotype A was assessed via logistic regression with exponentiated coefficients (odds ratios). Unsupervised phenotyping used k-means clustering with silhouette analysis across k = 2\u20266. Results: Patients with AIT were older (median 40 vs. 35 years; p = 0.021). Phenotype distribution differed by AIT status (overall p = 0.029), with phenotype A less frequent among AIT-positive women (27% vs. 40%). In adjusted robust regression, AIT was associated with lower HDL by \u03b2 = \u22124.34 mg\/dL (95% CI \u22129.18 to 0.51; p = 0.081), while obesity (\u22127.04 mg\/dL; p &lt; 0.001) and diabetes (\u22126.47 mg\/dL; p = 0.004) were associated with lower HDL. AIT was not associated with the composite metabolic score (\u03b2 = \u22120.005; 95% CI \u22121.22 to 1.21; p = 0.994), whereas obesity was associated with higher score (\u03b2 = 1.76; p = 0.003) and urban residence with lower score (\u03b2 = \u22120.94; p = 0.011). In logistic regression, AIT was associated with lower odds of phenotype A (OR 0.63; 95% CI 0.41\u20130.97; p = 0.038), and hypertension was associated with higher odds of phenotype A (OR 1.91; 95% CI 1.20\u20133.04; p = 0.006). Silhouette analysis supported k=3 clusters (silhouette 0.349), and AIT prevalence was highest in cluster 3 (26.4%) versus clusters 1 (19.9%) and 2 (18.3%). Conclusions: AIT was associated with lower odds of phenotype A, and showed a borderline association with lower HDL-cholesterol but not with a composite metabolic score. Data-driven clustering identified a subgroup with higher autoimmune burden.<\/jats:p>","DOI":"10.3390\/medicina62061184","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:25:34Z","timestamp":1781778334000},"page":"1184","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid Autoimmunity in Polycystic Ovary Syndrome: Phenotype Distribution, HDL-Cholesterol, and Data-Driven Clusters in a Retrospective Cohort Study"],"prefix":"10.3390","volume":"62","author":[{"given":"Raluca-Anamaria","family":"Mogo\u0219","sequence":"first","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9112-7039","authenticated-orcid":false,"given":"Alexandru","family":"Carauleanu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4718-392X","authenticated-orcid":false,"given":"Ingrid-Andrada","family":"Vasilache","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biological Sciences, \u2018\u0218tefan cel Mare\u2019 University, 720229 Suceava, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Juliette","family":"Mogo\u0219","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Ungureanu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letitia","family":"Leustean","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8200-6969","authenticated-orcid":false,"given":"Iustina-Petra","family":"Condriuc","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra-Teodora","family":"Gavril","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecaterina Tomaziu-Todosia","family":"Anton","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Preda","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Biological Sciences, \u2018\u0218tefan cel Mare\u2019 University, 720229 Suceava, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ho, C.-W., Chen, H.-H., Hsieh, M.-C., Chen, C.-C., Hsu, S.-P., Yip, H.-T., and Kao, C.-H. (2020). Increased risk of polycystic ovary syndrome and it\u2019s comorbidities in women with autoimmune thyroid disease. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17072422"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1530\/EC-18-0309","article-title":"Association between PCOS and autoimmune thyroid disease: A systematic review and meta-analysis","volume":"7","author":"Romitti","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12020-025-04181-3","article-title":"The prevalence of autoimmune thyroiditis is not increased in women with polycystic ovary syndrome after adjustment for family predisposition","volume":"88","author":"Vryonidou","year":"2025","journal-title":"Endocrine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejogrb.2013.03.003","article-title":"High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome","volume":"169","author":"Garelli","year":"2013","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_5","first-page":"215","article-title":"The assessment of thyroid autoantibody levels in euthyroid patients with polycystic ovary syndrome","volume":"19","year":"2018","journal-title":"J. Turk. Ger. Gynecol. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"33563","DOI":"10.1038\/s41598-025-18582-x","article-title":"Prevalence of anti-thyroid peroxidase antibodies among women with polycystic ovary syndrome","volume":"15","author":"Zahra","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e33205","DOI":"10.1097\/MD.0000000000033205","article-title":"Assessment of glucose and lipid metabolism in patients with polycystic ovary syndrome with and without Hashimoto\u2019s thyroiditis","volume":"102","author":"Jia","year":"2023","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2147\/DMSO.S300015","article-title":"A Comparative Study on Insulin Secretion, Insulin Resistance and Thyroid Function in Patients with Polycystic Ovary Syndrome with and without Hashimoto\u2019s Thyroiditis","volume":"14","author":"Zhao","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e260422204034","DOI":"10.2174\/1573399818666220426090324","article-title":"Is There a Relation between Hypothyroidism and Polycystic Ovary Syndrome and its Metabolic Components?","volume":"19","author":"Bonakdaran","year":"2023","journal-title":"Curr. Diabetes Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Katarzyna, S., \u017beber-Lubecka, N., Grymowicz, M., Roman, S., Kulecka, M., and Ewa, E.H. (2025). Autoimmune Processes and Chronic Inflammation as Independent Risk Factors for Metabolic Complications in Women with Polycystic Ovary Syndrome. Metabolites, 15.","DOI":"10.3390\/metabo15030141"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s40618-024-02404-4","article-title":"Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: A single-center experience","volume":"47","author":"Benelli","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Adamska, A., Agnieszka, \u0141., Anna, K., Justyna, H., Adamski, M., Lesniewska, M., Polak, A., and Kowalska, I. (2020). Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women with Different Polycystic Ovary Syndrome Phenotypes. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00440"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0043-110480","article-title":"Impact of autoimmune thyroiditis on reproductive and metabolic parameters in patients with polycystic ovary syndrome","volume":"126","author":"Ulrich","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2537275","DOI":"10.1080\/09513590.2025.2537275","article-title":"Effect of impaired sensitivity to thyroid hormones on the risk of insulin resistance and dyslipidemia in polycystic ovary syndrome patients","volume":"41","author":"You","year":"2025","journal-title":"Gynecol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e250226","DOI":"10.1530\/JOE-25-0226","article-title":"Phenotypic variations in polycystic ovary syndrome: Metabolic risks and emerging biomarkers","volume":"267","author":"Ma","year":"2025","journal-title":"J. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Balogh, Z., Csehely, S., Orosz, M., Bhattoa, H.P., Krasznai, Z.T., Deli, T., and Jakab, A. (2025). Relations of Insulin Resistance, Body Weight, Vitamin D Deficiency, SHBG and Androgen Levels in PCOS Patients. Biomedicines, 13.","DOI":"10.3390\/biomedicines13081803"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gawron, I.M., Baran, R., Derbisz, K., and Jach, R. (2022). Association of Subclinical Hypothyroidism with Present and Absent Anti-Thyroid Antibodies with PCOS Phenotypes and Metabolic Profile. J. Clin. Med., 11.","DOI":"10.3390\/jcm11061547"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kwiatkowski, J., Akpang, N., Zaborowska, L., and Ludwin, A. (2025). Prevalence and Levels of Thyroid Autoantibodies in Polycystic Ovary Syndrome\u2014Impact of TSH- and BMI-Matched Comparisons: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157525"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"A740","DOI":"10.1210\/jendso\/bvab048.1505","article-title":"Evaluation of Thyroid Function and Its Relationship with Metabolic Parameters in Indian Adolescents with PCOS","volume":"5","author":"Talwar","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.53730\/ijhs.v6nS5.10565","article-title":"study regarding the interrelation between subclinical hypothyroidism & insulin resistance among PCOS women","volume":"6","author":"Rosivari","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2067087","DOI":"10.1155\/2016\/2067087","article-title":"Subclinical hypothyroidism in PCOS: Impact on presentation, insulin resistance, and cardiovascular risk","volume":"2016","author":"Yu","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gencer, G., Serin, A., and Gencer, K. (2023). Analysis of the effect of hashimoto\u2019s thyroiditis and insulin resistance on ovarian volume in patients with polycystic ovary syndrome. BMC Women\u2019s Health, 23.","DOI":"10.1186\/s12905-023-02200-x"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/14647273.2019.1709668","article-title":"Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls","volume":"25","author":"Kim","year":"2022","journal-title":"Hum. Fertil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3329\/jafmc.v11i1.30676","article-title":"Association of Thyroid Stimulating Hormone with Insulin Resistance in Women with Polycystic Ovarian Syndrome","volume":"11","author":"Begum","year":"2016","journal-title":"J. Armed Forces Med. Coll. Bangladesh"},{"key":"ref_25","first-page":"481","article-title":"Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: Is there a relationship?","volume":"12","author":"Enzevaei","year":"2014","journal-title":"Iran. J. Reprod. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/jhrs.jhrs_155_24","article-title":"Assessment of Thyroid Auto-antibodies in Euthyroid Infertile Women with Polycystic Ovarian Syndrome\u2014A Cross-sectional Analytical Study","volume":"17","author":"Anusha","year":"2024","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_28","first-page":"e17954","article-title":"Detection of Thyorid Autoimmunity Markers in Euthyroid Women with Polycystic Ovary Syndrome: A Case-Control Study From Syria","volume":"12","author":"Haddad","year":"2014","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13224-016-0914-y","article-title":"Antithyroid Peroxidase Antibodies in Women with Polycystic Ovary Syndrome","volume":"67","author":"Menon","year":"2017","journal-title":"J. Obs. Gynaecol. India"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:07:00Z","timestamp":1781780820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061184"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061184","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}